Skip to content

Study of Karpas mool kalka in White discharege

A Open Randomized Control Clinical Trial Of Karpas Mool Kalka In Shewetapradara With Special Reference To Leucorrhoea.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038852
Enrollment
68
Registered
2021-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N768- Other specified inflammation of vagina and vulva

Interventions

None listed

Sponsors

Hon Shri Annasaheb Dange Ayurved Medical College And Post Graduate Research Cente Ashta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient will selected on the basis of signs & symptoms mentioned below: • Age from 20-45yrs of females patients complaining of shwetapradara.

Exclusion criteria

Exclusion criteria: 1)Pregnant women 2)Indication of surgical management and other complications 3)Cervical erosion 4)CA of genital tract 5)STDâ??s (syphilis, Tricomonas vaginalis) 6)VDRL, HbsAg, HIV positive person. 7)DM,HTN

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Karpas mool kalka in ShwetapradaraTimepoint: 18 months

Secondary

MeasureTime frame
To Compare the efficacy of Karpas mool kalka and Amalaki beej kalka in ShwetapradaraTimepoint: 18 months

Countries

India

Contacts

Public ContactVd Sachin Jagnnath Patil

Hon.Shri.Annasaheb Dange Ayurved Medical College And Post Graduate Research Centre Ashta,

sachinpatil5190@gmail.com9422407301

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026